Exposure to gastric juice may not cause adenocarcinogenesis of the esophagus

scientific article published on April 2013

Exposure to gastric juice may not cause adenocarcinogenesis of the esophagus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V19.I15.2419
P932PMC publication ID3631996
P698PubMed publication ID23613638
P5875ResearchGate publication ID236277578

P2093author name stringJun Gong
Lian-Feng Zhang
Peng Cheng
Jian-Sheng Li
Yong-Zhong Chen
P2860cites workPrevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study.Q53495209
Use of Proton Pump Inhibitors and Risk of Progression of Barrett's Esophagus to Neoplastic LesionsQ57259537
[Studies of experimental model of reflux esophagitis in rats by ligature on both lower portion of duodenum and most of forestomach]Q72390520
A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contentsQ80059918
Do acid and bile reflux into the esophagus simultaneously? Temporal relationship between duodenogastro-esophageal reflux and esophageal pHQ80183778
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidenceQ81290009
High animal-fat intake changes the bile-acid composition of bile juice and enhances the development of Barrett's esophagus and esophageal adenocarcinoma in a rat duodenal-contents reflux modelQ81295197
Emerging concepts of bile reflux in the constellation of gastroesophageal reflux diseaseQ84564393
The severity of duodeno-esophageal reflux influences the development of different histological types of esophageal cancer in a rat modelQ84953135
Epidemiology and pathogenesis of esophageal cancerQ28213313
Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomyQ33779762
Gastroesophageal reflux disease: From pathophysiology to treatmentQ34063683
Experimental Evidence for Mutagenic Potential of Duodenogastric Juice on Barrett’s EsophagusQ35560021
Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?Q35790574
Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal refluxQ36398679
Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessmentQ36787647
Esophageal adenocarcinoma in "mice and men": back to basics!Q37290141
Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicityQ37568033
Endoscopic evaluation and treatment of esophageal cance.Q37639850
The Pathogenesis of Barrett’s Metaplasia and the Progression to Esophageal AdenocarcinomaQ37777076
New pharmacologic approaches in gastroesophageal reflux diseaseQ37800666
A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in ratsQ42447080
Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in ratsQ42495110
Inactivation of the Wwox gene accelerates forestomach tumor progression in vivoQ43203616
Melatonin protects against experimental reflux esophagitisQ46207524
Association between cholecystectomy and adenocarcinoma of the esophagus.Q50181828
The mutagenic potential of duodenoesophageal reflux.Q50486949
P433issue15
P407language of work or nameEnglishQ1860
P304page(s)2419-2424
P577publication date2013-04-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleExposure to gastric juice may not cause adenocarcinogenesis of the esophagus
P478volume19

Search more.